Navigation Links
Report examines what US can learn from EU chemicals law
Date:2/27/2012

BLOOMINGTON, Ind. -- U.S. industry and environmental groups agree that the Toxic Substances Control Act (TSCA) of 1976 needs to be modernized to better protect public health and the environment. However, there is no consensus on what the reform should look like.

A new report from Indiana University supplies a close examination of the European Union's reformed chemicals law REACH (Registration, Evaluation, Authorization and Restriction of Chemicals), which went into effect in 2006.

After reviewing data and interviewing key stakeholders, including manufacturers, importers and REACH experts, researchers from the IU School of Public and Environmental Affairs and the IU European Union Center have released "Regulating Industrial Chemicals: Lessons for U.S. Policy Makers From the European Union's REACH Program."

"As the U.S. Congress considers whether and how to modernize TSCA, much can be learned from the European experience with REACH," said SPEA Dean John D. Graham, a co-author of the report. "Some aspects of REACH are innovative and promising, while others are overly burdensome and complicated."

While the report examines all areas of REACH, the primary focus is on the program's chemical registration process. REACH shifts the burden of proving safety from the government to industry. REACH's key principle -- "no data, no market" -- compels manufacturers of substances, producers of articles and importers to supply regulators a minimum safety-related data set for a large number of existing chemicals.

"One of our most important conclusions is that there needs to be a clear and consistent definition of 'safety' throughout any new chemical regulatory program," said the report's lead author, Adam Abelkop, a doctoral student in SPEA.

Researchers have identified several aspects of the EU program that merit consideration by U.S. policymakers as well as areas that could be refined and modified to be more transparent, simplified and suitable for the U.S. context. Highlights of the report indicate that a REACH-like system in the United States should focus on opportunities to reduce risks to human health and the environment. In addition, new legislation should provide clarification about critical standards, processes and tools while lessening unnecessary burdens on industry by allowing for mutual, cross-Atlantic recognition of registration dossiers.

"This suggestion would ease obligations on companies that do business on both sides of the Atlantic and would lessen the work of the regulators," said REACH consultant Agnes Botos, co-author of the report and a Central European University doctoral student. "That is why it would be worth doing a more detailed analysis about this topic."

According to SPEA professor Lois Wise, co-author of the report and director of the European Union Center and West European Studies at IU, REACH offers an alternative approach to the process of chemical regulation and control providing a greater understanding of how regulatory processes work.

"Our interest is in the extent to which the European experience implementing this complicated and innovative piece of legislation can inform efforts to revise TSCA," she said. "This study, examining the process of REACH implementation, provides useful insight for policymakers."

On March 2, SPEA and the European Union Center will host an invitation-only seminar in Washington, D.C., that includes a panel of international experts who will discuss Europe's early experiences with REACH and issues related to TSCA reform.


'/>"/>
Contact: Debbie O'Leary
devoleary@gmail.com
812-327-0018
Indiana University
Source:Eurekalert

Related medicine news :

1. Earliest Known Horse Shrank Due to Warming Planet: Report
2. 15% of U.S. Surgeons Report Drinking Problems in Survey
3. New MDC Research Report published
4. U.S. Teen Driving Deaths Up: Report
5. 1 in 10 U.S. Kids Lives With Parent Who Has Abused Alcohol: Report
6. UCLA scientists report link between traumatic brain injury, post-traumatic stress disorder
7. Orthopaedic surgery report provides transparency on patient safety, quality initiatives
8. Fewer Teens Exposed to Tobacco Smoke in Cars: Report
9. Medical debt keeps rising, new report shows
10. More U.S. Babies Born at Home: Report
11. Scientists report first step in strategy for cell replacement therapy in Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... ... Periodontist Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative ... by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a ...
(Date:1/20/2017)... ... ... Source Vitál Apothecary, a skin and body care company dedicated to creating ... a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition Conference in ... nutritional, sports and health industries a chance to meet in private sessions with some ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has ... 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic and have ... workout. , After a successful launch in Sweden last year, the next generation ...
(Date:1/20/2017)... ... 2017 , ... “I Forgive You”: a fine examination of how God handles sin, including ... of published author, Stephen Miller, who, for over ten long years has been waiting to ... in Trinidad and Tobago, he has been serving the Lord for over twenty years, and ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
(Date:1/19/2017)... 2017 Report Details ... Alzheimer,s Disease Therapeutics ... – our new study reveals trends, R&D progress, and ... affecting the Alzheimer,s disease therapeutics and diagnostics market. Our ... questions: - How is the Alzheimer,s disease therapeutics and ...
(Date:1/19/2017)... 19, 2017 According to a study conducted ... set to witness a CAGR of 6.5% during the forecast period ... will continue to be the leading market for cryotherapy globally during ... ... on ensuring affordable and adequate supply of gas in order to ...
Breaking Medicine Technology: